Compatibility study of patiromer with juices/liquids and soft foods

Author:

Khoeiklang Martin,Wilhelm Maria,Li Lingyun,Quinn Carol P. Moreno

Abstract

AbstractPatiromer powder for oral suspension (patiromer o.s.) is a once-daily, potassium (K+) binder approved for the treatment of hyperkalemia. It is known that patiromer o.s. can be mixed with water, apple juice, or cranberry juice. This in vitro study assessed whether mixing patiromer o.s. with a variety of other liquids and soft foods would affect the total K+-exchange capacity (TKEC) of patiromer. Juices (grape, orange, pear, or pineapple), nectars (apricot or peach), and other liquids/soft foods (milk, thickener, apple sauce, chocolate pudding, vanilla pudding, or yoghurt) were assessed for compatibility with patiromer o.s. at low and high ratio levels, equivalent to patiromer active moiety doses of 8.4 g and 25.2 g per 80 mL (1/3 cup), respectively. Mixtures were stirred, rested for 45 min, diluted with water, and centrifuged. Residues were washed, vacuum filtered, and dried. TKEC of the residue was evaluated; the prespecified acceptance criterion for patiromer was 8.4–10.0 mmol/g. Mean TKECs of the patiromer in juices/nectars were 8.7–8.9 mmol/g for the low ratio and 8.5–8.6 mmol/g for the high ratio. For other liquids/soft foods, the mean TKEC for patiromer at low and high ratios was 8.5–8.7 mmol/g. All tested vehicles were within the prespecified range. Mixing of patiromer o.s. with juices/liquids and soft foods does not adversely affect the K+-binding capability of patiromer. Use of different vehicles for suspending patiromer o.s. may help with its palatability, enhance patient experience, and reduce nonadherence. Graphical Abstract The potassium binder, patiromer powder for oral suspension, can be mixed with water, juices (apple, cranberry, grape, orange, pear, or pineapple), nectar (apricot or peach), other liquids (milk or thickener), and soft foods (apple sauce, chocolate or vanilla pudding, or yoghurt) for the treatment of hyperkalemia.

Funder

Vifor Pharma

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Reference15 articles.

1. Australian Government Department of Health Therapeutic Goods Administration (2019) Australian Public Assessment Report for patiromer sorbitex calcium. https://www.tga.gov.au/sites/default/files/auspar-patiromer-sorbitex-calcium-190911.pdf. Accessed 25 May 2022.

2. Brenner M, Panov N, Du Mond C et al (2016) Palatability profile of patiromer, a once-daily oral potassium binder for the treatment of hyperkalemia. Presented at American Society of Health-System Pharmacists Mid-Year Clinical Meeting, Las Vegas, Nevada, USA, 4–8 Dec 2016

3. Center for Drug Evaluation and Research (2015) Office Director Memo. Application: 205739Orig1s000 2015. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/205739Orig1s000ODMemo.pdf. Accessed 31 March 2022.

4. Cupisti A, Kovesdy CP, D’Alessandro C et al (2018) Dietary approach to recurrent or chronic hyperkalaemia in patients with decreased kidney function. Nutrients 10(3):261

5. Eat this much (2022) Nutrition facts. https://www.eatthismuch.com/. Accessed 31 March 2022.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3